Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bayer Comparing Vardenafil To Viagra In Attempt To Gain Edge In ED Market

Executive Summary

Bayer is conducting comparative trials of vardenafil and Pfizer's Viagra (sildenafil) in an attempt to establish the benefits of its investigative drug over other erectile dysfunction agents.

You may also be interested in...



Bayer Sheds R&D Projects Ahead Of Joint Venture, Is Flexible On Control

Bayer is reducing the size of its R&D pipeline through product eliminations and outlicensing opportunities to maximize its influence over a future pharmaceutical partnership, Management Board Chairman Werner Wenning announced Nov. 12

Bayer Sheds R&D Projects Ahead Of Joint Venture, Is Flexible On Control

Bayer is reducing the size of its R&D pipeline through product eliminations and outlicensing opportunities to maximize its influence over a future pharmaceutical partnership, Management Board Chairman Werner Wenning announced Nov. 12

BioPort Anthrax Vaccine Production Data To Be Submitted To FDA By Mid-Oct.

Anthrax vaccine manufacturer BioPort plans to submit data to FDA by Oct. 15 for approval of its renovated Lansing, Mich. plant.

Related Content

UsernamePublicRestriction

Register

PS038058

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel